Vir Biotechnology, Inc. Common Stock (VIR) Stock Price, Quote & AI Analysis

Live VIR stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Vir Biotechnology, Inc. Common Stock.

TradeVae provides AI-driven analysis and real-time market intelligence for Vir Biotechnology, Inc. Common Stock (VIR), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

VIR
Vir Biotechnology, Inc. Common Stock
real-time
$0.00 +0.00 (+0.00%)
Open
7.330000
High
7.825000
Low
7.250000
Volume
1,466,045
VWAP
-
Market Cap
$1,082,392,748.96
52W Range
$4.16 - $10.67
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
Feb 19, 2026 Q4
After Hours
EPS Estimate: $-0.4937
Revenue Estimate: $23,414,830.00
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Vir Biotechnology, Inc. Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Vir Biotechnology, Inc. Common Stock Overview

Company information

Company Overview

Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The firm's technology platforms include antibody, T cell, innate immunity and siRNA, which are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. The company was founded by Robert Taylor Nelsen, Klaus Frueh, Jay Parrish, Lawrence Corey, and Louis Picker in April 7, 2016 and is headquartered in San Francisco, CA.

Company Details
Market Cap
$1.07B
Shares Outstanding
139,125,032
Weighted Shares Outstanding
139,125,032
CEO
Marianne de Backer
Address
1800 OWENS STREET, SAN FRANCISCO, CA, 94158
Employees
408
Industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Vir Biotechnology, Inc. Common Stock Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...